Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2369551
Max Phase: Preclinical
Molecular Formula: C62H86N12O16
Molecular Weight: 1255.44
Molecule Type: Unknown
Associated Items:
ID: ALA2369551
Max Phase: Preclinical
Molecular Formula: C62H86N12O16
Molecular Weight: 1255.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@@H](C)[C@H]1NC(=O)[C@@H](NC(=O)c2c3nc4c(C(=O)N[C@@H]5C(=O)N[C@H]([C@H](C)CC)C(=O)N6CCC[C@H]6C(=O)N(C)CC(=O)N[C@@H](C(C)C)C(=O)O[C@@H]5C)ccc(C)c4oc-3c(C)c(=O)c2N)[C@@H](C)OC(=O)[C@H](C(C)C)NC(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O
Standard InChI: InChI=1S/C62H86N12O16/c1-15-29(7)44-59(84)73-23-17-19-36(73)57(82)71(13)25-38(75)64-42(27(3)4)61(86)88-33(11)46(55(80)67-44)69-53(78)35-22-21-31(9)51-48(35)66-49-40(41(63)50(77)32(10)52(49)90-51)54(79)70-47-34(12)89-62(87)43(28(5)6)65-39(76)26-72(14)58(83)37-20-18-24-74(37)60(85)45(30(8)16-2)68-56(47)81/h21-22,27-30,33-34,36-37,42-47H,15-20,23-26,63H2,1-14H3,(H,64,75)(H,65,76)(H,67,80)(H,68,81)(H,69,78)(H,70,79)/t29-,30-,33-,34-,36+,37+,42+,43+,44-,45-,46+,47+/m1/s1
Standard InChI Key: HFFOYFOCZZLABB-JPTGENBPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1255.44 | Molecular Weight (Monoisotopic): 1254.6285 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kim HK, Nam JY, Han MY, Son KH, Choi JD, Kwon BM, Takusagawa HL, Huang Y, Takusagawa F.. (2000) Natural and synthetic analogues of actinomycin D as Grb2-SH2 domain blockers., 10 (13): [PMID:10888331] [10.1016/s0960-894x(00)00258-4] |
Source(1):